These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

95 related items for PubMed ID: 7305629

  • 1. The response of cancer patients' lymphocytes to mitogen. The effect of indomethacin on adherent and non-adherent cells activity.
    Pituch-Noworolska A.
    Arch Immunol Ther Exp (Warsz); 1981; 29(2):161-5. PubMed ID: 7305629
    [Abstract] [Full Text] [Related]

  • 2. Indomethacin enhancement of immunocompetence in melanoma patients.
    Tilden AB, Balch CM.
    Surgery; 1981 Jul; 90(1):77-84. PubMed ID: 6972628
    [Abstract] [Full Text] [Related]

  • 3. Suppression of human lymphocyte responses in chronic renal failure mediated by adherent cells: analysis in serum-free media.
    Kleiman KS, Zoschke DC.
    J Lab Clin Med; 1985 Sep; 106(3):262-8. PubMed ID: 3928781
    [Abstract] [Full Text] [Related]

  • 4. Prostaglandin suppression of mitogen-stimulated lymphocytes in vitro. Changes with mitogen dose and preincubation.
    Goodwin JS, Messner RP, Peake GT.
    J Clin Invest; 1978 Oct; 62(4):753-60. PubMed ID: 701474
    [Abstract] [Full Text] [Related]

  • 5. In vitro effect of indomethacin on mitogen-induced lymphoproliferative response in lung cancer patients.
    Stanojević-Bakić N, Vucković-Dekić L, Susnjar S, Spuzić I.
    Neoplasma; 1992 Oct; 39(2):129-32. PubMed ID: 1326720
    [Abstract] [Full Text] [Related]

  • 6. N-acetyl-L-cysteine simultaneously increases mitogenesis and suppresses apoptosis in mitogen-stimulated B-lymphocytes from p53 haploinsufficient Tg.AC (v-Ha-ras) mice.
    Martin KR, Kari FW, Barrett JC, French JE.
    In Vitr Mol Toxicol; 2000 Oct; 13(4):237-48. PubMed ID: 11319275
    [Abstract] [Full Text] [Related]

  • 7. Activation of human T and non-T lymphocytes by sepharose-bound concanavalin A and the differential effect of macrophages.
    Terukina S, Arai S.
    Immunology; 1981 Oct; 44(2):215-22. PubMed ID: 6975235
    [Abstract] [Full Text] [Related]

  • 8. [Studies on the suppressor cells acting on the mitogen induced blastogenesis in tumor-bearing hosts. II. Suppressor cells in the peripheral blood of patients with malignant bone and soft tissue sarcoma (author's transl)].
    Takami M.
    Nihon Seikeigeka Gakkai Zasshi; 1980 Nov; 54(11):1563-70. PubMed ID: 6453175
    [Abstract] [Full Text] [Related]

  • 9. Regulation of the in vitro concanavalin A response of lymphocytes by cyclophosphamide-sensitive adherent cells--a possible role of Cy-sensitive regulatory cells.
    Ikezawa Z.
    Jpn J Exp Med; 1980 Aug; 50(4):225-35. PubMed ID: 7441904
    [Abstract] [Full Text] [Related]

  • 10. Enhancement of T lymphocyte proliferative response to mitogens by indomethacin in breast and colorectal cancer patients.
    Han T, Nemoto T, Ledesma EJ, Bruno S.
    Int J Immunopharmacol; 1983 Aug; 5(1):11-5. PubMed ID: 6601630
    [Abstract] [Full Text] [Related]

  • 11. Indomethacin enhancement of lymphocyte responses to phytohemagglutinin in breast, stomach and colorectal cancer patients.
    Kurosu Y, Arai T, Morita K.
    Jpn J Surg; 1988 Mar; 18(2):152-7. PubMed ID: 3392848
    [Abstract] [Full Text] [Related]

  • 12. Suppressor leukocytes in anergic patients with solid tumors.
    Bankhurst AD, Kauffman GR, Goodwin JS, Saiki JH, Saiers JH, Williams RC.
    J Clin Lab Immunol; 1980 May; 3(3):159-63. PubMed ID: 6448298
    [Abstract] [Full Text] [Related]

  • 13. Maximizing differences in the concanavalin A-induced blastogenic responses of lymphocytes from breast cancer patients and controls by the use of alpha-methyl-D-mannoside.
    Distasio JA, Cheresh DA, Schilder RJ, Vogel CL, Silverman MA, Lopez DM.
    J Natl Cancer Inst; 1982 Jan; 68(1):68-9. PubMed ID: 6948127
    [Abstract] [Full Text] [Related]

  • 14. An assay for monitoring response to therapy in cancer patients.
    Wilhide CC, Larcom LL.
    Ann Clin Lab Sci; 1993 Jan; 23(3):207-15. PubMed ID: 8323255
    [Abstract] [Full Text] [Related]

  • 15. Immune modulatory effects of indomethacin in melanoma patients are not related to prostaglandin E2-mediated suppression.
    Tilden AB, Balch CM.
    Surgery; 1982 Sep; 92(3):528-32. PubMed ID: 6287658
    [Abstract] [Full Text] [Related]

  • 16. The influence of surgery and anesthesia on lymphocyte functions in breast cancer patients: in vitro effects of indomethacin.
    Stanojević-Bakić N, Vucković-Dekić L, Radomirović S, Juranić Z, Jovanović N.
    Neoplasma; 1999 Sep; 46(1):54-60. PubMed ID: 10355535
    [Abstract] [Full Text] [Related]

  • 17. Evidence that prostaglandins modulate lipogenesis in cultured lymphocytes--a comparison with its effect on macrophages and tumour cells.
    de Bittencourt Júnior PI, Yano MM, Hirata MH, Williams JF, Curi R.
    Biochem Mol Biol Int; 1994 Jun; 33(3):463-75. PubMed ID: 7951065
    [Abstract] [Full Text] [Related]

  • 18. Evidence for the involvement of monocyte-derived toxic oxygen metabolites in the lymphocyte dysfunction of Hodgkin's disease.
    Deshazo RD, Ewel C, Londono S, Metzger Z, Hoffeld JT, Oppenheim JJ.
    Clin Exp Immunol; 1981 Nov; 46(2):313-20. PubMed ID: 7337972
    [Abstract] [Full Text] [Related]

  • 19. Differences in the effect of indomethacin and preincubation on the lymphoproliferative response to concanavalin A of spleen cells from low responder C57BL/6 and high responder BALB/c mice.
    Malavé I, Araujo Z.
    Int J Immunopharmacol; 1986 Nov; 8(2):137-46. PubMed ID: 3710662
    [Abstract] [Full Text] [Related]

  • 20. Primary in vitro antibody response in humans: role of adherent cells in the development of haemolytic colonies.
    Villa ML, Rappocciolo G, Piazza P.
    Immunology; 1986 Aug; 58(4):569-75. PubMed ID: 3460964
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.